Literature DB >> 28440642

Asymmetric Silica Nanoparticles with Tunable Head-Tail Structures Enhance Hemocompatibility and Maturation of Immune Cells.

Prasanna Lakshmi Abbaraju1, Anand Kumar Meka1, Hao Song1, Yannan Yang1, Manasi Jambhrunkar1, Jun Zhang1, Chun Xu1, Meihua Yu1, Chengzhong Yu1.   

Abstract

Asymmetric mesoporous silica nanoparticles (MSNs) with controllable head-tail structures have been successfully synthesized. The head particle type is tunable (solid or porous), and the tail has dendritic large pores. The tail length and tail coverage on head particles are adjustable. Compared to spherical silica nanoparticles with a solid structure (Stöber spheres) or large-pore symmetrical MSNs with fully covered tails, asymmetrical head-tail MSNs (HTMSNs) show superior hemocompatibility due to reduced membrane deformation of red blood cells and decreased level of reactive oxygen species. Moreover, compared to Stöber spheres, asymmetrical HTMSNs exhibit a higher level of uptake and in vitro maturation of immune cells including dendritic cells and macrophage. This study has provided a new family of nanocarriers with potential applications in vaccine development and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28440642     DOI: 10.1021/jacs.6b12622

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  11 in total

Review 1.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 2.  Biomedical applications of dendritic fibrous nanosilica (DFNS): recent progress and challenges.

Authors:  Mina Shaban; Mohammad Hasanzadeh
Journal:  RSC Adv       Date:  2020-10-08       Impact factor: 4.036

Review 3.  Advanced biomaterials for cancer immunotherapy.

Authors:  Fan Yang; Kun Shi; Yan-Peng Jia; Ying Hao; Jin-Rong Peng; Zhi-Yong Qian
Journal:  Acta Pharmacol Sin       Date:  2020-03-02       Impact factor: 6.150

Review 4.  Recent Progress on Asymmetric Carbon- and Silica-Based Nanomaterials: From Synthetic Strategies to Their Applications.

Authors:  Haitao Li; Liang Chen; Xiaomin Li; Daoguang Sun; Haijiao Zhang
Journal:  Nanomicro Lett       Date:  2022-01-17

Review 5.  Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy.

Authors:  Albert Yu; Xiaoyong Dai; Zixian Wang; Huaqing Chen; Bing Guo; Laiqiang Huang
Journal:  Biosensors (Basel)       Date:  2022-02-10

Review 6.  Application of non-metal nanoparticles, as a novel approach, for improving the stability of blood products: 2011-2021.

Authors:  Tahereh Zadeh Mehrizi; Mehdi Shafiee Ardestani
Journal:  Prog Biomater       Date:  2022-05-10

7.  Site-specific growth of MOF-on-MOF heterostructures with controllable nano-architectures: beyond the combination of MOF analogues.

Authors:  Chao Liu; Lina Lin; Qiang Sun; Jing Wang; Rong Huang; Wenyi Chen; Shumin Li; Jingjing Wan; Jin Zou; Chengzhong Yu
Journal:  Chem Sci       Date:  2020-03-05       Impact factor: 9.825

8.  Platelet-derived porous nanomotor for thrombus therapy.

Authors:  Mimi Wan; Qi Wang; Rongliang Wang; Rui Wu; Ting Li; Dan Fang; Yangyang Huang; Yueqi Yu; Leyi Fang; Xingwen Wang; Yinghua Zhang; Zhuoyue Miao; Bo Zhao; Fenghe Wang; Chun Mao; Qing Jiang; Xingquan Xu; Dongquan Shi
Journal:  Sci Adv       Date:  2020-05-27       Impact factor: 14.136

9.  Bottom-up self-assembly of heterotrimeric nanoparticles and their secondary Janus generations.

Authors:  Jianye Fu; Zhengying Gu; Yang Liu; Jun Zhang; Hao Song; Yannan Yang; Yang Yang; Owen Noonan; Jie Tang; Chengzhong Yu
Journal:  Chem Sci       Date:  2019-09-19       Impact factor: 9.825

10.  A dendritic cell-like biomimetic nanoparticle enhances T cell activation for breast cancer immunotherapy.

Authors:  Yanhua Li; Kun Tang; Xia Zhang; Wei Pan; Na Li; Bo Tang
Journal:  Chem Sci       Date:  2021-11-25       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.